Inventor · disambiguated record
Michaela Kneissel
Also filed as: KNEISSEL MICHAELA
4 granted patents·17 pending applications·53 citations·filing 2004–2024
74Inventor score
Top patents by PatentIndex Score
21 records- 0194US7879322B2Compositions and methods for use for antibodies against sclerostinNOVARTIS AG·Filed 2008·Granted Feb 1, 2011·48 cites·40 claims
- 0278US10961305B2Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2017·Granted Mar 30, 2021·3 cites·19 claims
- 0375US10028955B2FGFR inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2016·Granted Jul 24, 2018·2 cites·6 claims
- 0474US2024400666A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2024·Application pending·0 cites
- 0573US2024398798A1Fgfr inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0671US2023365669A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2023·Application pending·0 cites
- 0769US2025122273A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2024·Application pending·0 cites
- 0863US2021308132A1Fgfr inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0961US2021253684A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2020·Application pending·0 cites
- 1059US12173058B2Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2021·Granted Dec 24, 2024·0 cites·11 claims
- 1157US2009221503A1Use of rapamycin and rapamycin derivatives for the treatment of bone lossKNEISSEL MICHAELA·Filed 2009·Application pending·0 cites
- 1257US2020123242A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2020·Application pending·0 cites
- 1356US2010028335A1Compositions and Methods to Treat Bone Related DisordersNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1452US2020179509A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2017·Application pending·0 cites
- 1551US2015072019A1Fgfr inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1651US2013164284A1Compositions and methods to treat bone related disordersNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1749US2006173033A1Use of rapamycin and rapamycin derivatives for the treatment of bone lossKNEISSEL MICHAELA·Filed 2004·Application pending·0 cites
- 1847US2012232011A1Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone LossKNEISSEL MICHAELA·Filed 2012·Application pending·0 cites
- 1946US2012003219A1Compositions and Methods to Treat Bone Related DisordersLU CHRIS·Filed 2011·Application pending·0 cites
- 2042US2020181271A1Methods for preventing and treating urinary incontinenceNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2131US2013138221A1Methods and compositions for improving implant osseointegrationJUNKER UWE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →